Effect of Helicobacter pylori eradication on the natural history of duodenal ulcer disease

Arch Dis Child. 1998 Dec;79(6):502-5. doi: 10.1136/adc.79.6.502.

Abstract

Background: Duodenal ulcer disease is strongly associated with Helicobacter pylori infection of the gastric mucosa. Eradication of H pylori from the gastric mucosa in adults is associated with long term healing of ulcers.

Aims: To follow a cohort of children with duodenal ulcer disease for a minimum of two years after the eradication of H pylori.

Patients and methods: Over a three year period, all children diagnosed with duodenal ulcer disease had their symptoms documented and their H pylori status evaluated. The histories of these children were carefully screened to determine previous symptoms and to document previous treatment regimens.

Results: Sixteen children were diagnosed with ulcers and 15 were available for treatment and long term follow up. The median age at which symptoms first occurred was 10.5 years (range, 6-14) and the median duration of symptoms was 24 months (range, 2-60). Ten of the children had been treated with H2 receptor antagonists for a median of 3.5 months (range, 1-60). Duodenal ulcers healed in all children after eradication of H pylori and all children have remained asymptomatic for a median of 37 months (range, 26-62). No child has required subsequent admission to hospital.

Conclusion: Eradication of H pylori is very effective in the long term healing of duodenal ulcer disease. H pylori eradication should be the standard treatment for all infected children who present with duodenal ulcer disease.

MeSH terms

  • Adolescent
  • Amoxicillin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Drug Therapy, Combination
  • Duodenal Ulcer / drug therapy
  • Duodenal Ulcer / microbiology*
  • Follow-Up Studies
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori*
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Metronidazole / therapeutic use
  • Organometallic Compounds / therapeutic use
  • Tetracycline / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Histamine H2 Antagonists
  • Organometallic Compounds
  • Metronidazole
  • Amoxicillin
  • Tetracycline
  • bismuth tripotassium dicitrate